retatrutide clinical trials weight loss retatrutide VisualAbstract: reduces body by 17.5% in patients with obesity Experimental drug Retatrutide shows promising

The mechanisms could include reduced inflammation, improved metabolic health, direct effects on brain reward pathways, or the psychological benefit of successful weight management

Some people lost up to 24% of their body weight

Before I get into the specific medications, I want to introduce a term that is essential to understanding them: incretin

Mounjaro improved blood sugar control and helped people lose more weight

At 10 months of treatment (T10), HbA1c was 5.4%, fasting glucose was 98 mg/dL, BMI was 38.3, PASI was 2.6 (92.2%), and DLQI was 0 (no effect of psoriasis on the patient) (Fig

In particular, the FDA is looking for additional information regarding certain manufacturing and release testing methods